A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo - PubMed (original) (raw)

Comparative Study

A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo

R Morishita et al. Proc Natl Acad Sci U S A. 1995.

Abstract

The application of DNA technology to regulate the transcription of disease-related genes in vivo has important therapeutic potentials. The transcription factor E2F plays a pivotal role in the coordinated transactivation of cell cycle-regulatory genes such as c-myc, cdc2, and the gene encoding proliferating-cell nuclear antigen (PCNA) that are involved in lesion formation after vascular injury. We hypothesized that double-stranded DNA with high affinity for E2F may be introduced in vivo as a decoy to bind E2F and block the activation of genes mediating cell cycle progression and intimal hyperplasia after vascular injury. Gel mobility-shift assays showed complete competition for E2F binding protein by the E2F decoy. Transfection with E2F decoy inhibited expression of c-myc, cdc2, and the PCNA gene as well as vascular smooth muscle cell proliferation both in vitro and in the in vivo model of rat carotid injury. Furthermore, 2 weeks after in vivo transfection, neointimal formation was significantly prevented by the E2F decoy, and this inhibition continued up to 8 weeks after a single transfection in a dose-dependent manner. Transfer of an E2F decoy can therefore modulate gene expression and inhibit smooth muscle proliferation and vascular lesion formation in vivo.

PubMed Disclaimer

Similar articles

Cited by

References

    1. N Engl J Med. 1994 May 19;330(20):1431-8 - PubMed
    1. Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8474-8 - PubMed
    1. EMBO J. 1987 Jun;6(6):1643-51 - PubMed
    1. Nucleic Acids Res. 1987 Aug 25;15(16):6419-36 - PubMed
    1. EMBO J. 1987 Jul;6(7):2061-8 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources